Cresset Asset Management’s Trueblue TBI Stock Holding History

Cresset Asset Management’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-77	Closed	-$2K	–	1550
2019 Q1	$2K	Sell	77 -14	-15%	-$327	﹤0.01%	1690
2018 Q4	$2K	Buy	+91	New	+$2.18K	﹤0.01%	1368

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cresset Asset Management's TBI Position: Q2 2019 in Review

Cresset Asset Management sold out of Trueblue (TBI) in Q2 2019, closing a stake of 77 shares — an estimated $2K sold.

Cresset Asset Management first reported a position in TBI in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 185 funds tracked by Wall St. Rank hold TBI as of Q2 2019.

Cresset Asset Management reported no remaining Trueblue position as of Q2 2019 after selling out during the quarter.
Cresset Asset Management sold 77 Trueblue shares in Q2 2019, an estimated $2K.
Cresset Asset Management first reported a position in Trueblue in Q4 2018 and held it in 2 quarters.
Cresset Asset Management's Trueblue position peaked at $2K in Q1 2019.
185 funds tracked by Wall St. Rank held Trueblue as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.